Supernus Pharmaceuticals Inc.
SUPN | NASDAQ
$42.78
+$0.78 (+1.86%)
At close: Sep 21, 2026, 4:00 PM ET
$42.78
$0 (0.00%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 128.45M | 69.33M | 75.05M | 93.12M | 203.43M | 288.64M |
Short-Term Investments | 180.22M | 384.28M | 179.82M | 368.21M | 136.25M | 133.89M |
Long-Term Investments | n/a | n/a | 16.62M | 93.9M | 119.17M | 350.36M |
Other Long-Term Assets | 65.25M | 31.53M | 37.51M | 39.81M | 49.23M | 43.25M |
Receivables | 187.8M | 142.08M | 144.16M | 165.5M | 148.93M | 140.88M |
Inventory | 82.39M | 54.29M | 77.41M | 91.54M | 85.96M | 48.33M |
Other Current Assets | 65.33M | 36.09M | 16.68M | 15.78M | n/a | n/a |
Total Current Assets | 644.18M | 686.07M | 493.11M | 734.15M | 601.59M | 630.42M |
Property-Plant & Equipment | 10.53M | 11.55M | 13.53M | 15.17M | 16.96M | 37.82M |
Goodwill & Intangibles | 694.34M | 638.93M | 716.91M | 819.48M | 902.21M | 442.25M |
Total Long-Term Assets | 808.47M | 682M | 784.56M | 968.36M | 1.09B | 873.69M |
Total Assets | 1.45B | 1.37B | 1.28B | 1.7B | 1.69B | 1.5B |
Account Payables | 2.68M | 4.59M | 1.96M | 10.54M | 9.33M | 6.15M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | n/a | n/a | 401.97M | n/a | n/a |
Other Current Liabilities | 98.72M | 68.57M | 77.08M | 54.95M | 93.04M | 55.99M |
Total Current Liabilities | 338.17M | 292.4M | 290.2M | 687.96M | 315.38M | 245.11M |
Long-Term Debt | n/a | n/a | n/a | n/a | 379.25M | 361.75M |
Other Long-Term Liabilities | 22.4M | 7.6M | 7.8M | 42.54M | 52.02M | 68.36M |
Total Long-Term Liabilities | 52.76M | 39.94M | 65.96M | 128.35M | 557.92M | 514.14M |
Total Liabilities | 390.93M | 332.34M | 356.16M | 816.3M | 873.3M | 759.24M |
Total Debt | 40.98M | 34.27M | 41.53M | 444.76M | 427.03M | 414.33M |
Book Value | 1.06B | 1.04B | 921.52M | 886.2M | 815.85M | 744.86M |
Book Value Per Share | 18.81 | 18.51 | 16.60 | 14.37 | 15.01 | 13.87 |
Common Stock | 57K | 56K | 55K | 54K | 53K | 53K |
Retained Earnings | 517.88M | 556.43M | 482.56M | 481.25M | 379.92M | 326.5M |
Comprehensive Income | -44K | -189K | -593K | -3.21M | 1.54M | 8.98M |
Shareholders Equity | 1.06B | 1.04B | 921.52M | 886.2M | 815.85M | 744.86M |
Total Investments | 180.22M | 384.28M | 196.44M | 462.11M | 255.41M | 484.25M |
Add to Watchlist
Select watchlists to add or remove SUPN